Microbial Infections and Antimicrobial Resistance (AMR) Patterns Associated With Hospitalized Patients With 2019 Novel Coronavirus Disease (COVID 19)
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Assiut University
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- Microbial infections and antimicrobial resistance (AMR) patterns associated with hospitalized patients with 2019 novel coronavirus disease (COVID 19)
Study Overview
Brief Summary
To detect microbial infection and AMR associated with COVID 19 infection.
To correlate risk factors of COVID 19 patients with microbial infections and their effects on disease.
Detailed Description
The most common type of infection among ICU patients was bacterial or fungal pneumonia; bloodstream and urinary tract infections were also noted. Organisms cultured from patients included pandrug-resistant Acinetobacter baumannii, Klebsiella pneumoniae carbapenemase-producing K. pneumoniae, extended-spectrum β-lactamase (ESBL)- producing K. pneumoniae, ESBL-producing Pseudomonas aeruginosa, Enterobacter cloacae, Serratia marcescens, Aspergillus fumigatus, Aspergillus flavus, Candida albicans, and Candida glabrata .
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Prospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients with Covid infection
Exclusion Criteria
- •Patients without covid 19
Outcomes
Primary Outcomes
Microbial infections and antimicrobial resistance (AMR) patterns associated with hospitalized patients with 2019 novel coronavirus disease (COVID 19)
Time Frame: baseline
The correlation between microbial infection and COVID 19 infection and their effect on prognosis and disease outcome.
Secondary Outcomes
No secondary outcomes reported
Investigators
ALShymaa faheem solyman ali
assistant lecturer
Assiut University
